Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

ZEISS Quality Innovation Days

The leading digital event from April 15-19, 2024.

Pneumatics Makes a Technological Leap with Piezo

The first high-precision proportional valve terminal VTEP opens up new application areas

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...

Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president

In mid-summer, neuroscientist Marc Tessier-Lavigne announced his resignation as President of Stanford following allegations of manipulated study data. According...

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Björn Ursing: Physicians new role in AI driven healthcare

”AI could be the key we need for tomorrow’s healthcare, but it is not a stand-alone tool”, writes Björn Ursing in a column about how the role for physicians cha...

Genmab backade efter J&J:s licensavhopp

Danska Genmab faller tungt på börsen efter att Johnson & Johnson valt att inte gå vidare med en licensiering av bolagets läkemedelskandidat mot multipelt myelom.

Thermo Fisher köper Solventum-enhet för över 4 miljarder dollar

Förvärvet berör Solventums enhet för teknologier inom rening och filter som används vid tillverkningsprocesser.

40,000 DNA extractions daily

It's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat...

VGR pausar Millennium på obestämd tid

Under kaosartade former stoppades journalsystemet Millennium i höstas. Nu pausas införandet på obestämd tid, men Västra Götalandsregionen utesluter inte ett åte...

“We need to keep investing in research and innovation”

that the ambitions will be strong going forward”, says Jenni Nordborg.

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Förlikning i babypuderskandal stoppas av domstol

Det amerikanska läkemedelsbolaget Johnson & Johnson har för en andra gång fått avslag av en domare om en konkursansökan för dotterbolaget LTL Management, mest k...

Wusson Accelerator AB

Introduction of ZEISS Imaging Systems for Super-Resolution

Webinar recording about the ZEISS Lattice SIM technology.

Webinar: Clinical evaluation and clinical investigation of medical devices

Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.

Reliably gripping and turning small parts

The extremely compact rotary gripper module EHMD is the ideal choice in many life science applications where small objects need to be gripped and turned in conf...

Larm om vaccinbrist efter utbrott av difteri i Västafrika

Ett allvarligt utbrott av difteri har drabbat Västafrika. Nu varnar Läkare utan gränser för brist på läkemedel och vaccin mot sjukdomen.

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Webinar: Support Trial Patients Transitioning to the Commercial Space

Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.

Sanofi lägger ner projekt inom E. coli-vaccin

Sanofi lägger ner utvecklingen av ett nytt E. coli-vaccin efter ett misslyckande i sen klinisk fas.